AbbieVie to Pay Millions in Fines over AndroGel

[Jinzang]

AbbieVie has been ordered by a federal judge to pay $448 million dollars for filing phony lawsuits to delay the introduction of generic equivalents of AndroGel to the market, thus illegally maintaining its monopoly. The FTC press release says:

Federal Trade Commission Chairman Joe Simons issued the following statement regarding the decision by the U.S. District Court for the Eastern District of Pennsylvania in the case FTC v. AbbVie. The court ruled that AbbVie used sham litigation to illegally maintain its monopoly over the testosterone replacement drug Androgel, and ordered $448 million in monetary relief to consumers who were overcharged for Androgel as a result of AbbVie’s conduct. This court order represents the largest monetary award ever in a litigated FTC antitrust case.